Matti Nykter

15.1k total citations · 1 hit paper
152 papers, 5.6k citations indexed

About

Matti Nykter is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matti Nykter has authored 152 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 49 papers in Cancer Research and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matti Nykter's work include Prostate Cancer Treatment and Research (32 papers), Cancer Genomics and Diagnostics (21 papers) and Glioma Diagnosis and Treatment (15 papers). Matti Nykter is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Cancer Genomics and Diagnostics (21 papers) and Glioma Diagnosis and Treatment (15 papers). Matti Nykter collaborates with scholars based in Finland, United States and Canada. Matti Nykter's co-authors include Matti Annala, Ilya Shmulevich, Kim N., Alexander W. Wyatt, Kevin Beja, David Cogdell, Martin Gleave, Tapio Visakorpi, Kexin Chen and Olli Yli‐Harja and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Nucleic Acids Research.

In The Last Decade

Matti Nykter

146 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

2018 347 citations Matti Annala, Gillian Vandekerkhove et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matti Nykter Finland	39	3.0k	2.4k	1.9k	988	456	152	5.6k
Matthew D. Wilkerson United States	21	3.3k 1.1×	1.9k 0.8×	2.1k 1.1×	1.3k 1.3×	788 1.7×	72	5.7k
Kyle Ellrott United States	13	4.4k 1.5×	2.4k 1.0×	935 0.5×	1.2k 1.2×	458 1.0×	28	6.2k
Dan R. Robinson United States	31	5.2k 1.8×	3.8k 1.6×	1.2k 0.6×	1.5k 1.6×	679 1.5×	101	7.6k
Yun Xiao China	34	3.8k 1.3×	2.5k 1.0×	954 0.5×	784 0.8×	769 1.7×	181	5.5k
Yidong Chen United States	37	4.3k 1.5×	1.7k 0.7×	1.4k 0.7×	1.6k 1.6×	698 1.5×	83	7.3k
Andrea Sboner United States	42	3.5k 1.2×	1.9k 0.8×	3.0k 1.6×	1.6k 1.6×	242 0.5×	139	6.7k
Michael D. Story United States	41	3.6k 1.2×	1.6k 0.7×	1.6k 0.9×	1.5k 1.5×	445 1.0×	158	6.3k
Feng Jiang United States	50	5.7k 1.9×	3.9k 1.6×	1.2k 0.6×	1.8k 1.8×	396 0.9×	134	8.4k
Johan Botling Sweden	39	2.8k 0.9×	1.2k 0.5×	1.1k 0.6×	1.6k 1.6×	1.1k 2.3×	117	5.3k
Jianjun Yu China	26	6.4k 2.1×	2.8k 1.1×	2.4k 1.3×	1.9k 2.0×	951 2.1×	64	8.9k

Countries citing papers authored by Matti Nykter

Since Specialization

Citations

This map shows the geographic impact of Matti Nykter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Nykter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Nykter more than expected).

Fields of papers citing papers by Matti Nykter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Nykter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Nykter. The network helps show where Matti Nykter may publish in the future.

Co-authorship network of co-authors of Matti Nykter

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Nykter. A scholar is included among the top collaborators of Matti Nykter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Nykter. Matti Nykter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salonen, I, Kristiina Nordfors, Hannu Haapasalo, et al.. (2025). Unsupervised clustering reveals noncanonical myeloid cell subsets in the brain tumor microenvironment. Cancer Immunology Immunotherapy. 74(2). 63–63.

Nykter, Matti, et al.. (2025). The inflammasome adaptor pycard is essential for immunity against Mycobacterium marinum infection in adult zebrafish. Disease Models & Mechanisms. 18(9). 2 indexed citations

Kallio, Heini, Synnöve Staff, Kati Kivinummi, et al.. (2024). Sensitive circulating tumor DNA–based residual disease detection in epithelial ovarian cancer. Life Science Alliance. 7(6). e202402658–e202402658. 7 indexed citations

Aittomäki, Saara, Mickaël J. Ploquin, Juha Kesseli, et al.. (2023). FURIN regulates cytotoxic T‐lymphocyte effector function and memory cell transition in mice. European Journal of Immunology. 53(6). e2250246–e2250246. 3 indexed citations

Aakula, Anna, Francesco Tabaro, Matthieu Schapira, et al.. (2023). RAS and PP2A activities converge on epigenetic gene regulation. Life Science Alliance. 6(5). e202301928–e202301928. 7 indexed citations

Kaljunen, Heidi, Sinja Taavitsainen, Ville Paakinaho, et al.. (2023). Fanconi anemia pathway regulation by FANCI in prostate cancer. Frontiers in Oncology. 13. 1260826–1260826. 3 indexed citations

Vandekerkhove, Gillian, Jean‐Michel Lavoie, Matti Annala, et al.. (2021). Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer. Nature Communications. 12(1). 184–184. 109 indexed citations

Annala, Matti, Sinja Taavitsainen, Daniel Khalaf, et al.. (2021). Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition. Clinical Cancer Research. 27(16). 4610–4623. 52 indexed citations

Ketola, Kirsi, Heidi Kaljunen, Sinja Taavitsainen, et al.. (2021). Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer Research. 81(19). 4901–4909. 8 indexed citations

10.

Granberg, Kirsi J., Erika Gucciardo, Hannu Haapasalo, et al.. (2021). CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity. JCI Insight. 6(9). 37 indexed citations

11.

Kesseli, Juha, et al.. (2021). Proprotein convertase subtilisin/kexin type 9 regulates the production of acute‐phase reactants from the liver. Liver International. 41(10). 2511–2522. 8 indexed citations

12.

Pölönen, Petri, Juha Mehtonen, Jake Lin, et al.. (2019). Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies. Cancer Research. 79(10). 2466–2479. 19 indexed citations

13.

Annala, Matti, Gillian Vandekerkhove, Daniel Khalaf, et al.. (2018). Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer. Cancer Discovery. 8(4). 444–457. 347 indexed citations breakdown →

14.

Kesseli, Juha, et al.. (2018). Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma. Cancer Research. 78(19). 5574–5585. 54 indexed citations

15.

Scaravilli, Mauro, Wilhelmiina Niininen, Hanna Karvonen, et al.. (2018). Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies. Translational Oncology. 11(5). 1160–1170. 22 indexed citations

16.

Kallio, Heini, Reija Hieta, Leena Latonen, et al.. (2018). Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases. British Journal of Cancer. 119(3). 347–356. 66 indexed citations

17.

Vandekerkhove, Gillian, Tilman Todenhöfer, Matti Annala, et al.. (2017). Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer. Clinical Cancer Research. 23(21). 6487–6497. 122 indexed citations

18.

Saramäki, Outi R., Matti Annala, Katri A. Leinonen, et al.. (2016). 1074 Microseminoprotein-beta expression in different stages of prostate cancer. European Urology Supplements. 15(3). e1074–e1074. 2 indexed citations

19.

Ylipää, Antti, Kati Kivinummi, Matti Annala, et al.. (2015). Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer. Cancer Research. 75(19). 4026–4031. 58 indexed citations

20.

Yang, Jilong, Antti Ylipää, Yan Sun, et al.. (2011). Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment. Clinical Cancer Research. 17(24). 7563–7573. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact